SPY328.68+2.16 0.66%
DIA266.11+1.76 0.67%
IXIC10,874.43+129.15 1.20%

Citigroup Upgrades Dr Reddy's Laboratories to Buy

Citigroup analyst Prashant Nair upgrades Dr Reddy's Laboratories (NYSE:RDY) from Sell to Buy.

Benzinga · -

Citigroup analyst Prashant Nair upgrades Dr Reddy's Laboratories (NYSE:RDY) from Sell to Buy.